Pulmonx Affirms FY2026 Sales Guidance of $90.000M-$92.000M vs $90.832M Est
Pulmonx (NASDAQ: LUNG ) affirms FY2026 sales outlook from $90.000 million-$92.000 million to $90.000 million-$92.000 million vs $90.832 million estimate.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.